05-03-2021 12:37 PM | Source: Reuters
Pfizer in talks with India over expedited approval for COVID-19 vaccine
NEW DELHI - Pfizer is in discussions with the Indian government seeking an "expedited approval pathway" for its COVID-19 vaccine, its CEO Albert Bourla said on LinkedIn on Monday, announcing a donation of medicines worth more than $70 million.
"Unfortunately, our vaccine is not registered in India although our application was submitted months ago," he said.
"We are currently discussing with the Indian government an expedited approval pathway to make our Pfizer-BioNTech vaccine available for use in the country."
Latest News
Insurance Sector Update : Motor drags down overall g...
Sell Gold Below 72700 SL Above 72950 TGT 72400/72100...
Wipro shares nosedived over 9 pc after missed earnin...
Economic Survey links mental health disorders with '...
India's GDP growth for FY25 to surpass Economic Surv...
Evening Roundup : A Daily Report on Bullion Energy &...
FIIs stood as net buyers in equities as per July 22 ...
Union Budget: Experts urge government to remove 18 ...
Poonawalla Fincorp AUM up 52% YoY to Rs 26,972 crore...
Sensex ends lower ahead of Union Budget 2024-25